21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Gene and Cell Therapy”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Gene and Cell Therapy”. The paper list is as follows:
1. “Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy“
by Rúben Faria, Milan Paul, Swati Biswas, Eric Vivès, Prisca Boisguérin, Ângela Sousa and Diana Costa
Pharmaceutics 2022, 14(4), 757; https://doi.org/10.3390/pharmaceutics14040757
Available online: https://www.mdpi.com/1999-4923/14/4/757
2. “IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation”
by Ahmed E. I. Hamouda, Kai Schulze, Thomas Ebensen, Carlos Alberto Guzmán and Darío Lirussi
Pharmaceutics 2022, 14(12), 2821; https://doi.org/10.3390/pharmaceutics14122821
Available online: https://www.mdpi.com/1999-4923/14/12/2821
3. “Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio”
by Anja Lena Thiebes, Sarah Klein, Jonas Zingsheim, Georg H. Möller, Stefanie Gürzing, Manuel A. Reddemann, Mehdi Behbahani, Stefan Jockenhoevel and Christian G. Cornelissen
Pharmaceutics 2022, 14(11), 2421; https://doi.org/10.3390/pharmaceutics14112421
Available online: https://www.mdpi.com/1999-4923/14/11/2421
4. “Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells”
by Yutong He, Dongdong Bi, Josée A. Plantinga, Grietje Molema, Jeroen Bussmann and Jan A. A. M. Kamps
Pharmaceutics 2022, 14(10), 2086; https://doi.org/10.3390/pharmaceutics14102086
Available online: https://www.mdpi.com/1999-4923/14/10/2086
5. “Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy“
by Ana Raquel Neves, Tânia Albuquerque, Rúben Faria, Ana M. Gonçalves, Cecília Santos, Eric Vivès, Prisca Boisguérin, Luís A. Passarinha, Ângela Sousa and Diana Costa
Pharmaceutics 2022, 14(10), 2213; https://doi.org/10.3390/pharmaceutics14102213
Available online: https://www.mdpi.com/1999-4923/14/10/2213
6. “Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations”
by Ahmed Salman, Ariel Kantor, Michelle E. McClements, Gemma Marfany, Sonia Trigueros and Robert E. MacLaren
Pharmaceutics 2022, 14(9), 1842; https://doi.org/10.3390/pharmaceutics14091842
Available online: https://www.mdpi.com/1999-4923/14/9/1842
7. “The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA”
by Laura Taina-González and María de la Fuente
Pharmaceutics 2022, 14(2), 460; https://doi.org/10.3390/pharmaceutics14020460
Available online: https://www.mdpi.com/1999-4923/14/2/460
8. “A Narrative Review of Cell-Based Approaches for Cranial Bone Regeneration”
by Maria I. Falguera Uceda, Silvia Sánchez-Casanova, Clara Escudero-Duch and Nuria Vilaboa
Pharmaceutics 2022, 14(1), 132; https://doi.org/10.3390/pharmaceutics14010132
Available online: https://www.mdpi.com/1999-4923/14/1/132
You can check all publications in the Section “Gene and Cell Therapy” at the following link: https://www.mdpi.com/search?journal=pharmaceutics§ion=1033.